StockData
InMed Pharmaceuticals Inc. logo

InMed Pharmaceuticals Inc. (MTRI) income statement

MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30
$15.24−0.04 (-0.26%)

Close on Nov 19, 2026Market cap $83.75MP/E –Yield –

InMed Pharmaceuticals Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2026
-173.1%

Financial strength

Current ratio
–
Debt to equity
–
Debt to assets
–
Cash to current liabilities
–

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?